Cargando…

Autoantibodies directed against α1-adrenergic receptor and endothelin receptor A in patients with prostate cancer

BACKGROUND: For prostate cancer, signaling pathways induced by over-boarding stimulation of G-protein coupled receptors (GPCR) such as the endothelin, α1- and β-adrenergic, muscarinic and angiotensin 1 receptors were accused to support the carcinogenesis. However, excessive receptor stimulation by p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wallukat, Gerd, Jandrig, Burkhard, Becker, Niels-Peter, Wendler, Johann J., Göttel, Peter, Müller, Johannes, Schostak, Martin, Schimke, Ingolf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519497/ https://www.ncbi.nlm.nih.gov/pubmed/32977857 http://dx.doi.org/10.1186/s13317-020-00136-y

Ejemplares similares

Functional autoantibodies in patients with different forms of dementia
por: Wallukat, Gerd, et al.
Publicado: (2018)

Correction: Functional autoantibodies in patients with different forms of dementia
por: Wallukat, Gerd, et al.
Publicado: (2018)

Doberman pinschers present autoimmunity associated with functional autoantibodies: A model to study the autoimmune background of human dilated cardiomyopathy
por: Wess, Gerhard, et al.
Publicado: (2019)

Are Agonistic Autoantibodies against G-Protein Coupled Receptors Involved in the Development of Long-Term Side Effects of Tumor Chemotherapy?
por: Haberland, Annekathrin, et al.
Publicado: (2013)

A Three-Part, Randomised Study to Investigate the Safety, Tolerability, Pharmacokinetics and Mode of Action of BC 007, Neutraliser of Pathogenic Autoantibodies Against G-Protein Coupled Receptors in Healthy, Young and Elderly Subjects
por: Becker, Niels-Peter, et al.
Publicado: (2020)

The aptamer BC 007 for treatment of dilated cardiomyopathy: evaluation in Doberman Pinschers of efficacy and outcomes
por: Werner, Sabine, et al.
Publicado: (2020)

Agonistic autoantibodies against ß2-adrenergic receptor influence retinal microcirculation in glaucoma suspects and patients
por: Hohberger, Bettina, et al.
Publicado: (2021)

Potential Relevance of α(1)-Adrenergic Receptor Autoantibodies in Refractory Hypertension
por: Wenzel, Katrin, et al.
Publicado: (2008)

Inhibitory and Agonistic Autoantibodies Directed Against the β(2)-Adrenergic Receptor in Pseudoexfoliation Syndrome and Glaucoma
por: Hohberger, Bettina, et al.
Publicado: (2021)

Autoantibodies Activating the β2-Adrenergic Receptor Characterize Patients With Primary and Secondary Glaucoma
por: Hohberger, Bettina, et al.
Publicado: (2019)

Agonistic Autoantibodies to the β2-Adrenergic Receptor Involved in the Pathogenesis of Open-Angle Glaucoma
por: Jünemann, Anselm, et al.
Publicado: (2018)

Agonistic β2-Adrenergic Receptor Autoantibodies Characterize the Aqueous Humor of Patients With Primary and Secondary Open-Angle Glaucoma
por: Hohberger, Bettina, et al.
Publicado: (2021)

Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms
por: Wallukat, Gerd, et al.
Publicado: (2021)

Antigen-free control wells in an ELISA set-up for the determination of autoantibodies against G protein-coupled receptors—a requisite for correct data evaluation
por: Haberland, Annekathrin, et al.
Publicado: (2018)

Animals Experimentally Infected with SARS-CoV-2 Generate Functional Autoantibodies against G-Protein-Coupled Receptors
por: Wallukat, Gerd, et al.
Publicado: (2023)

Activation of neuronal endothelin B receptors mediates pressor response through alpha‐1 adrenergic receptors
por: Becker, Bryan K., et al.
Publicado: (2017)

Glaucoma and Alzheimer: Neurodegenerative disorders show an adrenergic dysbalance
por: Hohberger, Bettina, et al.
Publicado: (2022)

Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis
por: Kill, Angela, et al.
Publicado: (2014)

β(1)-adrenergic receptor O-glycosylation regulates N-terminal cleavage and signaling responses in cardiomyocytes
por: Park, Misun, et al.
Publicado: (2017)

Case Report: Neutralization of Autoantibodies Targeting G-Protein-Coupled Receptors Improves Capillary Impairment and Fatigue Symptoms After COVID-19 Infection
por: Hohberger, Bettina, et al.
Publicado: (2021)

Difference between beta1-adrenoceptor autoantibodies of human and animal origin—Limitations detecting beta1-adrenoceptor autoantibodies using peptide based ELISA technology
por: Wenzel, Katrin, et al.
Publicado: (2018)

Functional and mutational analysis after radiation and cetuximab treatment on prostate carcinoma cell line DU145
por: Schneider, Raik, et al.
Publicado: (2021)

Performance and in-house validation of a bioassay for the determination of beta1-autoantibodies found in patients with cardiomyopathy
por: Wenzel, Katrin, et al.
Publicado: (2017)

Clinical and prognostic associations of autoantibodies recognizing adrenergic/muscarinic receptors in patients with heart failure
por: Markousis-Mavrogenis, George, et al.
Publicado: (2023)

Impact of human autoantibodies on β(1)-adrenergic receptor conformation, activity, and internalization
por: Bornholz, Beatrice, et al.
Publicado: (2013)

α(1A)-Adrenergic Receptor-Directed Autoimmunity Induces Left Ventricular Damage and Diastolic Dysfunction in Rats
por: Wenzel, Katrin, et al.
Publicado: (2010)

β-Adrenergic Receptor Signaling in Prostate Cancer
por: Braadland, Peder Rustøen, et al.
Publicado: (2015)

A Molecularly Characterized Preclinical Platform of Subcutaneous Renal Cell Carcinoma (RCC) Patient-Derived Xenograft Models to Evaluate Novel Treatment Strategies
por: Gürgen, Dennis, et al.
Publicado: (2022)

Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patients
por: Günther, Jeannine, et al.
Publicado: (2014)

Increased circulating β(2)-adrenergic receptor autoantibodies are associated with smoking-related emphysema
por: Hu, Jia-yi, et al.
Publicado: (2017)

Autoantibodies against M(5)-muscarinic and beta(1)-adrenergic receptors in periodontitis patients
por: Scherbaum, Isabel, et al.
Publicado: (2020)

Endothelin Receptors and Their Antagonists()()
por: Maguire, Janet J., et al.
Publicado: (2015)

Activation of T Lymphocytes as a Novel Mechanism in Beta1-Adrenergic Receptor Autoantibody-Induced Cardiac Remodeling—Additional Information About TLR9 Involvement
por: Haberland, Annekathrin, et al.
Publicado: (2019)

Expression of Endothelin-1, Endothelin Receptor-A, and Endothelin Receptor-B in facial melasma compared to adjacent skin
por: da Silva, Carolina Nunhez, et al.
Publicado: (2023)

Endotheliitis, endothelin, and endothelin receptor blockers in COVID-19
por: Sanghavi, Devang K., et al.
Publicado: (2021)

β(1) Adrenergic Receptor Autoantibodies and IgG Subclasses: Current Status and Unsolved Issues
por: Kawai, Akane, et al.
Publicado: (2023)

New aspects in shear-wave elastography of prostate cancer
por: Porsch, Markus, et al.
Publicado: (2015)

Effect of prazosin on diabetic nephropathy patients with positive α1-adrenergic receptor autoantibodies and refractory hypertension
por: ZHAO, LIN-SHUANG, et al.
Publicado: (2015)

Author Correction: Increased circulating β2-adrenergic receptor autoantibodies are associated with smoking-related emphysema
por: Hu, Jia-yi, et al.
Publicado: (2020)

The Role of Endothelin-1 and Endothelin Receptor Antagonists in Inflammatory Response and Sepsis
por: Kowalczyk, Agata, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_i8r6jo4c875c7enei90a9i9cv2